— Know what they know.
Not Investment Advice

GNLKQ OTC

GeneLink, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -60.0% 5Y: -95.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $10601 mcap · 161M float · 0.0003% daily turnover

Cash Flow Trends

Operating Cash Flow
-$2M +17.8% ▲
Capital Expenditures
$242K -485.5% ▼
5Y CAGR: +21.6%
Free Cash Flow
-$3M +10.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$582K -287.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2008FY2009FY2010FY2011FY2012
— Operating Activities —
Net Income-$3M-$3M-$3M-$4M-$3M
Depreciation & Amort.$87K$126K$160K$135K$213K
Stock-Based Comp.$0$0$417K$357K$293K
Change in Working Capital$441K-$320K$400K$259K$685K
Other Non-Cash Items$625K$362K$317K$178K-$522K
Operating Cash Flow-$1M-$3M-$1M-$3M-$2M
— Investing Activities —
Capital Expenditures-$281K-$121K-$124K-$41K-$242K
Acquisitions (Net)$0$0$0$0$539K
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$281K-$121K-$124K-$41K$297K
— Financing Activities —
Net Debt Issuance-$56K-$120K$0$204K$0
Stock Repurchased-$237K$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$762K$1M$0$750K$0
Financing Cash Flow$1M$2M$2M$3M$2M
Net Change in Cash-$537K-$238K$232K$311K-$582K
Cash End of Period$435K$197K$429K$741K$158K
Free Cash Flow-$2M-$3M-$1M-$3M-$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms